CN110054597B - Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof - Google Patents

Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof Download PDF

Info

Publication number
CN110054597B
CN110054597B CN201910306156.5A CN201910306156A CN110054597B CN 110054597 B CN110054597 B CN 110054597B CN 201910306156 A CN201910306156 A CN 201910306156A CN 110054597 B CN110054597 B CN 110054597B
Authority
CN
China
Prior art keywords
reaction
thiazolidine
metal catalyst
solvent
ketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201910306156.5A
Other languages
Chinese (zh)
Other versions
CN110054597A (en
Inventor
王随乾
韦锋
李晓芳
张兴国
张小红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou University
Original Assignee
Wenzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou University filed Critical Wenzhou University
Priority to CN201910306156.5A priority Critical patent/CN110054597B/en
Publication of CN110054597A publication Critical patent/CN110054597A/en
Application granted granted Critical
Publication of CN110054597B publication Critical patent/CN110054597B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a thiazolidine-4-ketone derivative synthesized under the condition of no metal catalyst and a preparation method thereof, N-aryl (alkyl) -3-aryl propynamide is taken as a substrate, sodium sulfide or potassium sulfide is added into the substrate to be taken as a sulfur source, dichloromethane or dibromomethane is taken as a carbon source to react, a reaction solvent is tetrahydrofuran or acetonitrile or 1,4-dioxane solvent, the reaction temperature is 80 ℃, and the reaction time is 14-16 hours; the whole reaction is carried out under normal pressure, the reaction condition is mild and is easy to achieve, meanwhile, the reaction time is short, and the time cost is low; the reactant raw materials are easy to obtain, no metal catalyst is used, and the raw material cost is low. A series of thiazolidine-4-ketone derivatives are prepared, and the method has stronger substrate universality; provides powerful guarantee for developing the medicine containing thiazolidine-4-ketone derivatives.

Description

Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof
Technical Field
The invention relates to the field of organic synthesis, in particular to thiazolidine-4-ketone derivatives synthesized under the condition of no metal catalyst and a preparation method thereof.
Background
Thiazolidin-4-one scaffolds are important structures in bioactive compounds and drug molecules (eur.j.med.chem.2007, 42,948-954, bioor.med.chem.lett.2001,11, 1179-179), and their derivatives have biological activities of antibacterial, antiviral, anti-inflammatory, and anticancer, and have attracted widespread interest in academia (bioorg.med.chem.2006, 14,7476-7481 bioorg.med.chem.2008,16, 3714-3724.
In 1947, alexander R et al first reported that thiazolidinone is obtained by reacting Schiff base and mercaptoacetic acid (j.am.chem.soc.1947, 69 (11), 2911-2912.), and then with the development of research, the research method for synthesizing thiazolidinone by using aldehyde, amine and mercaptoacetic acid as starting materials and a three-component one-pot method is one of the main methods for synthesizing thiazolidinone at present, for example, in 2010, zhang Jinchao, a subject group synthesizes thiazolidine-4-one derivative (j.org.chem., 2010,30,611-616) with pharmaceutical activity by using diethyl tartrate, mercaptoacetic acid and aromatic amine through a multi-step method, but the method has complicated synthesis steps and low economic value; in order to reduce reaction steps and improve economic value; liu et al directly synthesized thiazolidin-4-one derivatives (Y.Liu, X.Chen, Y.Liu, RSC adv.2017,7,37839, X.Chen, C.Hu, J. -P.Wan, Y.Liu, tetrahedron Lett.2016,57,5116) in one step by taking dihaloalkane as a carbon source, but the cost is still too high because copper and noble metal Pd are used as catalysts to participate in the reaction; so that the applicability of these methods is greatly limited.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a thiazolidine-4-ketone derivative synthesized under the condition of no metal catalyst and a preparation method thereof, and the preparation method does not need a metal catalyst and directly synthesizes the thiazolidine-4-ketone derivative by a one-step method.
In order to achieve the purpose, the invention provides the following technical scheme: a thiazolidine-4-ketone derivative synthesized under the condition of no metal catalyst, the molecular structural formula of which is shown in the specification
Figure BDA0002029890750000021
wherein-R 1 Is any one of phenyl, 4-methylphenyl, 4-methoxyphenyl, 2-methoxyphenyl and n-butyl; -R 2 Is any one of phenyl, 4-methylphenyl and 4-methoxyphenyl.
As a further improvement of the invention, the thiazolidine-4-ketone derivative is prepared by reacting N-aryl (alkyl) -3-aryl propynamide, a carbon source and a sulfur source;
the reaction formula is as follows:
Figure BDA0002029890750000022
as a further improvement of the invention, the sulfur source is sodium sulfide or potassium sulfide.
As a further improvement of the invention, the carbon source is dichloromethane or dibromomethane.
As a further improvement of the invention, the preparation method of thiazolidine-4-ketone derivatives synthesized under the condition of no metal catalyst comprises the steps of sequentially putting N-phenyl-3-phenyl propynamide, a sulfur source and a carbon source into a reaction vessel filled with a solvent, stirring and mixing to obtain a reaction solution; then raising the temperature for reaction; and after the reaction is finished, filtering and purifying the reaction solution to obtain the thiazolidine-4-ketone derivative.
As a further improvement of the invention, the solvent is tetrahydrofuran or acetonitrile or 1,4-dioxane.
As a further improvement of the invention, the reaction is carried out by raising the temperature, namely raising the temperature of the reaction solution to 80 ℃ and the reaction time to 14-16h.
As a further improvement of the invention, the filtration and purification treatment means that the reaction solution is filtered, rotary evaporated, separated by a column layer, eluted by liquid, and finally concentrated in vacuum to obtain the thiazolidine-4-ketone derivative.
As a further development of the invention, the eluent comprises the following composition of matter in parts by volume:
10 parts of petroleum ether;
and 1 part of ethyl acetate.
The invention has the beneficial effects that: n-aryl (alkyl) -3-aryl propiolamide is taken as a substrate, sodium sulfide or potassium sulfide is added into the substrate as a sulfur source, dichloromethane or dibromomethane is taken as a carbon source for reaction, a reaction solvent is tetrahydrofuran or acetonitrile or 1,4-dioxane solvent, the reaction temperature is 80 ℃, and the reaction time is 14-16 hours; the whole reaction is carried out under normal pressure, the reaction condition is mild and is easy to achieve, meanwhile, the reaction time is short, and the time cost is low; the raw materials of the reactants are easy to obtain, no metal catalyst is used, the reaction process is environment-friendly, the atom economy is high, the raw material cost is low, and the industrial value is high.
After the reaction is finished, cooling, filtering the reaction solution to obtain filtrate, then carrying out rotary evaporation on the filtrate, and removing the solvent to obtain a residue. Eluting the residue by a silica gel column with an eluent prepared from petroleum ether and ethyl acetate according to the volume ratio of 10 to 1, collecting the effluent according to an actual gradient, detecting by TLC, combining the effluent containing the target product, removing the solvent by rotating the combined effluent by a rotary evaporator, and finally drying in vacuum to obtain the target product. A series of thiazolidine-4-ketone derivative derivatives are prepared, and the method has stronger substrate universality. Therefore, the invention fills the blank of the method for preparing the thiazolidine-4-ketone derivative at the present stage, promotes the development of the polysubstituted thiazolidine-4-ketone derivative and provides a powerful guarantee for developing the medicine containing the thiazolidine-4-ketone derivative.
The invention does not need to separate intermediate products, can directly synthesize the target product by simple raw materials, simplifies the process, has less waste solution in the reaction process, does not discharge other polluted gas and liquid, and has the advantages of protecting the environment and ensuring the health of operators.
Drawings
FIG. 1 is a reaction mechanism diagram of the first embodiment of the present invention.
Detailed Description
The first embodiment is as follows: 44.2 mg (0.2 mmol) of N-phenyl-3-phenylpropionamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL of dichloromethane, added to 2mL of solvent THF. The reaction was stirred at 80 ℃ for 15 hours. Cooling after the reaction is finished, filtering the reaction solution to obtain a filtrate, carrying out rotary evaporation on the filtrate to remove the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, eluting the residue by using a mixed solution of petroleum ether and ethyl acetate with the volume ratio of 10, 1 H NMR(400MHz,CDCl 3 )δ7.70-7.64(m,4H),7.56-7.49(m,5H),7.42-7.39(m,1H),7.36-7.34(m,1H),5.23(s,2H).
the second embodiment is as follows: 47.0 mg (0.2 mmol) of N-phenyl-3- (p-tolyl) propynamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL methylene chlorideAdded to 2mL of THF as a solvent. The reaction was stirred at 80 ℃ for 16 hours. And cooling after the reaction is finished, filtering the reaction liquid to obtain a filtrate, carrying out rotary evaporation on the filtrate, removing the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, carrying out elution by using a mixed solution of petroleum ether and ethyl acetate with the volume ratio of 10, collecting effluent liquid according to an actual gradient, carrying out TLC detection, combining the effluent liquid containing the product, distilling by using a rotary evaporator to remove the solvent, and carrying out vacuum drying to obtain a white solid, (Z) -5-benzyl-3- (p-tolyl) thiazolidin-4-one. 1 H NMR(400MHz,CDCl 3 )δ7.66-7.61(m,3H),7.51-7.47(m,4H),7.39-7.36(m,1H),7.31-7.29(m,2H),5.01(s,2H),2.42(s,3H). 13 C NMR(125MHz,CDCl 3 )δ165.3,136.7,136.3,135.2,129.9,129.4,128.7,128.3,126.4,125.7,122.9,47.8,21.0.
The third concrete example: 50.2 mg (0.2 mmol) of N-phenyl-3- (4-methoxyphenyl) propynamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL of dichloromethane, added to 2mL of THF, a solvent. The reaction was stirred at 80 ℃ for 14 hours. And cooling after the reaction is finished, filtering the reaction solution to obtain a filtrate, carrying out rotary evaporation on the filtrate, removing the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, eluting the residue by using a mixed solution of petroleum ether and ethyl acetate with the volume ratio of 10. 1 H NMR(400MHz,CDCl 3 )δ7.65-7.61(m,3H),7.51-7.47(m,4H),7.39-7.36(m,1H),7.03-7.01(m,2H),5.00(s,2H),3.88(s,3H). 13 C NMR(125MHz,CDCl 3 )δ164.3,157.3,134.2,130.6,128.4,127.7,127.3,125.3,124.7,123.8,113.6,54.4,47.0.
The fourth concrete example: 50.2 mg (0.2 mmol) of N-phenyl-3- (2-methoxyphenyl) propynamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL of dichloromethane, added to 2mL of solvent THF. The reaction was stirred at 80 ℃ for 15 hours. And cooling after the reaction is finished, filtering the reaction solution to obtain filtrate, carrying out rotary evaporation on the filtrate, removing the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, leaching the residue by using a mixed solution of petroleum ether and ethyl acetate with the volume ratio of 10Collecting effluent, detecting by TLC, combining the effluent containing the product, distilling by a rotary evaporator to remove the solvent, and drying in vacuum to obtain white solid (Z) -5-benzyl-3- (2-methoxyphenyl) thiazolidin-4-one. 1 H NMR(400MHz,CDCl 3 )δ7.64-7.63(m,3H),7.52-7.48(m,2H),7.45-7.36(m,3H),7.12-7.06(m,2H),4.92(s,2H),3.90(s,3H). 13 C NMR(125MHz,CDCl 3 )δ166.2,155.2,135.3,129.9,129.4,129.3,128.7,128.1,126.5,126.1,125.5,121.2,112.3,55.8,47.3.
The fifth concrete example: 43.80 mg (0.2 mmol) of N-butyl-3-phenylpropionamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL of dichloromethane, added to 2mL of solvent THF. The reaction was stirred at 80 ℃ for 15 hours. And (2) cooling after the reaction is finished, filtering the reaction liquid to obtain a filtrate, carrying out rotary evaporation on the filtrate to remove the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, eluting the residue by using a mixed solution of petroleum ether and ethyl acetate in a volume ratio of 10, collecting effluent liquid according to an actual gradient, carrying out TLC detection, combining the effluent liquid containing the product, distilling by using a rotary evaporator to remove the solvent, and carrying out vacuum drying to obtain a white solid (Z) -5-benzyl-3-butylthiazolidine-4-ketone. 1 HNMR(400MHz,CDCl 3 )δ7.59-7.54(m,3H),7.48-7.44(m,2H),7.36-7.32(m,1H),4.62(s,2H),3.61(t,J=9Hz,2H),1.70-1.63(m,2H),1.47-1.38(m,2H),1.01(t,J=9.5Hz,2H) 13 C NMR(125MHz,CDCl 3 )δ166.2,135.3,129.2,128.7,128.0,126.0,125.3,46.6,44.9,29.4,20.0,13.7.
The sixth specific embodiment: 50.2 mg (0.2 mmol) of N- (4-methoxyphenyl) -3-phenylpropionamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL of dichloromethane, added to 2mL of solvent THF. The mixture was stirred at 80 ℃ for 15 hours. And (2) cooling after the reaction is finished, filtering the reaction liquid to obtain a filtrate, carrying out rotary evaporation on the filtrate to remove the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, eluting the residue by using a mixed solution of petroleum ether and ethyl acetate with the volume ratio of 10, collecting effluent liquid according to an actual gradient, carrying out TLC (thin-layer chromatography) detection, combining the effluent liquid containing the product, distilling by using a rotary evaporator to remove the solvent, and carrying out vacuum drying to obtain a white solid (Z) -5- (4-methoxybenzyl) -3-phenylthiazolidine-4-ketone. 1 H NMR(400MHz,CDCl 3 )δ7.63-7.57(m,5H),7.52-7.48(m,2H),7.35-7.31(m,1H),7.04-7.01(m,2H),5.04(s,2H).3.90(s,3H). 13 C NMR(125MHz,CDCl 3 )δ165.6,159.7,139.0,131.0,129.3,127.9,126.5,122.8,122.7,114.3,55.4,47.6.
The seventh specific embodiment: 47.0 mg (0.2 mmol) of N- (4-methyl) phenyl-3-phenylpropionamide, 31.2 mg (0.4 mmol) of Na 2 S,1mL of dichloromethane, added to 2mL of solvent THF. The reaction was stirred at 80 ℃ for 15 hours. And cooling after the reaction is finished, filtering the reaction solution to obtain a filtrate, carrying out rotary evaporation on the filtrate, removing the solvent to obtain a residue, carrying out silica gel column chromatography on the residue, eluting the residue by using a mixed solution of petroleum ether and ethyl acetate with the volume ratio of 10. 1 H NMR(400MHz,CDCl 3 )δ7.66-7.61(m,3H),7.54-7.48(m,4H),7.35-7.29(m,3H),5.04(s,2H),2.44(s,3H). 13 C NMR(125MHz,CDCl 3 )δ165.8,139.3,138.9,132.6,129.8,129.7,129.6,127.0,126.8,124.7,123.0,47.9,21.7.
In the embodiment of the invention, N-aryl (alkyl) -3-aryl propiolamide is used as a substrate to react with 2.0-2.5 equivalents of sodium sulfide and 1mL of dichloromethane, and the solvent is based on tetrahydrofuran. Wherein examples one to five are R in N-aryl (alkyl) -3-arylpropynylamides 1 Substituted with different substituents as variables. It is noted that alkyl groups are also very good for use in the process of the invention; examples six to seven with R in N-aryl (alkyl) -3-arylpropynylamides 2 Substituted with different substituents as variables.
The general reaction formula of the invention is:
Figure BDA0002029890750000071
the reaction mechanism of the present invention: referring to fig. 1, the following description is made by taking the first embodiment as an example: n-phenyl-3-phenyl propynamide is used as a substrate; firstly, carrying out electrophilic addition reaction on sodium sulfide and a substrate to obtain a thiolene negative ion intermediate A, carrying out once [1,4] hydrogen migration on active nitrogen hydrogen in A to obtain an intermediate B, and carrying out nucleophilic substitution on B and dichloromethane to obtain a target product (Z) -5-benzyl-3-phenylthiazolidine-4-ketone.
The invention discloses (Z) -5-benzyl-3-aryl (alkyl) thiazole-alkane 4-ketone synthesized under the condition of no metal catalyst and a method thereof, N-aryl (alkyl) -3-aryl propynamide is taken as a substrate, sodium sulfide or potassium sulfide is added into the substrate as a sulfur source, methylene dichloride or dibromomethane is taken as a carbon source for reaction, a reaction solvent is tetrahydrofuran or acetonitrile or 1,4-dioxane solvent, the reaction temperature is 80 ℃, and the reaction time is 14-16 hours; the whole reaction is carried out under normal pressure, the reaction temperature is less than 100 ℃, the reaction condition is mild and easy to achieve, and meanwhile, the reaction time is short and the time cost is low; the reactant raw materials are easy to obtain, no metal catalyst is used, and the raw material cost is low.
After the reaction is finished, cooling, filtering the reaction solution to obtain filtrate, then carrying out rotary evaporation on the filtrate, and removing the solvent to obtain a residue. Eluting the residue by a silica gel column with an eluent prepared from petroleum ether and ethyl acetate according to the volume ratio of 10 to 1, collecting the effluent according to an actual gradient, detecting by TLC, combining the effluent containing the target product, removing the solvent by rotating the combined effluent by a rotary evaporator, and finally drying in vacuum to obtain the target product. A series of thiazolidine-4-ketone derivative derivatives are prepared, and the method has stronger substrate universality. Therefore, the invention fills the blank of the method for preparing the thiazolidine-4-ketone derivative at the present stage, promotes the development of the polysubstituted thiazolidine-4-ketone derivative and provides a powerful guarantee for developing the medicine containing the thiazolidine-4-ketone derivative.
According to the invention, the intermediate product does not need to be separated, the target product can be directly synthesized by simple raw materials, the process is simplified, the waste solution in the reaction process is less, other polluted gases and liquid are not discharged, and the method has the advantages of protecting the environment and guaranteeing the health of operators; in the above examples, a series of thiazolidine-4-ketone derivative derivatives can be prepared by selecting N-aryl (alkyl) -3-aryl propiolamide containing different substituents to participate in the reaction, and the method has certain substrate universality and operation simplicity.
The above description is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiments, and all technical solutions belonging to the idea of the present invention belong to the protection scope of the present invention. It should be noted that modifications and adaptations to those skilled in the art without departing from the principles of the present invention should also be considered as within the scope of the present invention.

Claims (4)

1. A method for preparing thiazolidine-4-ketone derivatives synthesized under the condition of no metal catalyst is characterized in that: the reaction formula is as follows
Figure 422848DEST_PATH_IMAGE001
Wherein R1 is any one of phenyl, 4-methylphenyl, 4-methoxyphenyl, 2-methoxyphenyl and n-butyl;
-R2 is any one of phenyl, 4-methylphenyl, 4-methoxyphenyl;
the sulfur source is sodium sulfide or potassium sulfide; the carbon source is dichloromethane or dibromomethane;
the reaction steps are as follows: will be provided with
Figure 871147DEST_PATH_IMAGE002
Sequentially putting the sulfur source and the carbon source into a reaction container filled with a solvent, and stirring and mixing to obtain a reaction solution; then raising the temperature for reaction; after the reaction is finished, filtering and purifying the reaction solution to obtain thiazolidine-4-ketone derivatives;
the reaction is carried out by raising the temperature, namely raising the temperature of the reaction solution to 80 ℃ and the reaction time to 14-16h.
2. The process according to claim 1, wherein the synthesis of thiazolidin-4-one derivatives is carried out in the absence of a metal catalyst, wherein: the solvent is tetrahydrofuran or acetonitrile or 1,4-dioxane.
3. The method according to claim 2, wherein the thiazolidin-4-one derivative is synthesized in the absence of a metal catalyst, and the method comprises the steps of: the filtration and purification treatment refers to that the reaction solution is filtered, rotary evaporated, separated by column layers, eluted liquid is leached, and finally the thiazolidine-4-ketone derivative is obtained by vacuum concentration.
4. The process according to claim 3, wherein the synthesis of the thiazolidin-4-one derivative is carried out in the absence of a metal catalyst, and wherein: the eluent comprises the following substances in parts by volume: 10 parts of petroleum ether; and 1 part of ethyl acetate.
CN201910306156.5A 2019-04-17 2019-04-17 Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof Expired - Fee Related CN110054597B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910306156.5A CN110054597B (en) 2019-04-17 2019-04-17 Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910306156.5A CN110054597B (en) 2019-04-17 2019-04-17 Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof

Publications (2)

Publication Number Publication Date
CN110054597A CN110054597A (en) 2019-07-26
CN110054597B true CN110054597B (en) 2022-11-08

Family

ID=67317749

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910306156.5A Expired - Fee Related CN110054597B (en) 2019-04-17 2019-04-17 Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110054597B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329002A (en) * 1996-09-30 2002-01-02 辉瑞大药厂 Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329002A (en) * 1996-09-30 2002-01-02 辉瑞大药厂 Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Transition-metal and base-free thioannulation of propynamides with sodium sulfide and dichloromethane for the selective synthesis of 1,3- thiazin-4-ones and thiazolidine-4-ones";Sui-Qian Wang et al.;《Tetrahedron》;20200207;第76卷;第131021-131029页 *

Also Published As

Publication number Publication date
CN110054597A (en) 2019-07-26

Similar Documents

Publication Publication Date Title
Tan et al. Concise synthesis of chiral 2 (5H)-furanone derivatives possessing 1, 2, 3-triazole moiety via one-pot approach
CN108314658B (en) A kind of preparation method of polysubstituted oxazole derivatives
CN108794357B (en) N-difluoromethyl hydrazone compound and synthesis method thereof
CN112812084B (en) Synthetic method of benzofuran compound
CN110054597B (en) Thiazolidine-4-ketone derivative synthesized under condition of no metal catalyst and preparation method thereof
CN104744390A (en) Preparation method of ezetimibe internmediate ketone
CN115108937B (en) Synthesis method of alpha-azido ketone containing three-level stereo center
CN105753733A (en) AHU377 crystal form and preparation method and uses thereof
CN111793017B (en) Preparation method of lactam compound
Ma et al. A concise and practical stereoselective synthesis of ipragliflozin L-proline
CN108610306B (en) Synthetic method of 2H-1, 4-thiazine-3 (4H) -ketone derivative
CN109053631B (en) Synthetic method for synthesizing benzo [1,3] oxazine-2-thioketone through isothiocyanate and 2-sulfonyl alkyl phenol
CN108191737B (en) Process for producing N- (2-methylthiophenyl) isoindole-1, 3-dione compound
Stachel et al. Synthesis of (±)-thioascorbic acid
CN109384753B (en) Synthetic method of 2-phenyl-3-methylbenzofuran compound
CN115521268B (en) Method for synthesizing iodo-alkenyl oxazolidone derivative
JP2008543742A5 (en)
JPS58172344A (en) Manufacture of phenylalkanoic acid
CN109970703A (en) The preparation method and application of 1,3- heterocyclic substituted aromatic ketone
JP2008543742A (en) Process for the preparation of biarylureas and their analogs
CN109879832B (en) 4-alkoxy-2-aryl mercaptomorpholine-3, 5-dione compound and preparation method thereof
CN111943891B (en) Rosuvastatin calcium impurity and rosuvastatin calcium quality control method
CN107382899A (en) A kind of polysubstituted benzo-oxazine derivative of 2 hydroxyl 1,4
CN112341444B (en) 3- (2, 3-dihydropyrrole) indole compound and preparation method thereof
CN107033056A (en) A kind of preparation method of the pyrrolin of 2 methyl, 4 phenyl 1

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20221108

CF01 Termination of patent right due to non-payment of annual fee